Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,005.00
Bid: 7,021.00
Ask: 7,022.00
Change: 147.00 (2.14%)
Spread: 1.00 (0.01%)
Open: 6,927.00
High: 7,023.00
Low: 6,849.00
Yest. Close: 6,858.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

MARKET COMMENT: UK Stocks To Open Higher With Earnings In Focus

31 Jul 14 06:25

AstraZeneca smashes forecasts in Q2 after seeing off Pfizer

LONDON, July 31 (Reuters) - AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival drugmaker Pfizer two months ago. Sales in the first quarter rose 4 percent to $6.45 billion, des

31 Jul 14 06:18

UK Earnings, Trading Statements Calendar - Week Ahead

31 Jul 14 05:24

MARKET COMMENT: UK Stocks Fall As US GDP Surge Turns Attention To Fed

30 Jul 14 16:34

UK Earnings, Trading Statements Calendar - Week Ahead

30 Jul 14 15:27

Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials

* Sanofi to file drug for US and EU approval by year-end * Nine Phase III ODYSSEY trials meet primary endpoint * Alirocumab "generally well tolerated" in trials By Natalie Huet PARIS, July 30 (Reuters) - A new drug being developed by French drugmaker Sanofi and U.S. partne

30 Jul 14 12:00

London midday: UK stocks flat ahead of US data, Fed decision

- Corporate earnings receive mixed market reaction - Barclays, Travis Perkins and Astra rise - Antofagasta, ITV and Compass fall - US data, Fed decision in focus later on techMARK 2,783.73 +0.05% FTSE 100 6,803.99 -0.06% FTSE 250 15,675.20 -0.08% The FTSE 100 was trading broadly flat on Wednesday,

30 Jul 14 11:42

UK MIDDAY BRIEFING: Barclays Leads FTSE 100 After Unexpected Profit Rise

30 Jul 14 11:29

UPDATE 3-AstraZeneca buys Almirall lung drugs for up to $2.1 billion

* Initial $875 mln payout, up to $1.22 bln more if goals hit * AstraZeneca gets access to Eklira and pipeline products * Disposal leaves Almirall focused on dermatology * Almirall shares jump 8 percent (Adds drug sales figure, Actavis role, Almirall ownership) By Ben Hir

30 Jul 14 11:11

UK WINNERS & LOSERS: Barclays Beat Sends Banks Higher

30 Jul 14 10:40

TOP NEWS: Barclays Beats Forecasts, Astra Buys Respiratory Business

30 Jul 14 10:32

London open: Stocks slip as investors digest earnings, Barclays rises

- Barclays rises as investors digest wave of corporate earnings - Russian sanctions, Gaza and Argentina in focus - US economic data, Fed decision due out later on techMARK 2,785.48 +0.12% FTSE 100 6,797.66 -0.15% FTSE 250 15,671.08 -0.10% UK markets opened slightly lower on Wednesday as investors

30 Jul 14 08:26

Astrazeneca to gain rights to Almirall's respiratory franchise

Astrazeneca has struck a deal with drug developer Almirall for the rights to the Spanish group's respiratory franchise. Under the agreement, which includes an initial consideration of $875m, the FTSE 100-listed company will gain the rights for the development and commercialisation of Almirall's ex

30 Jul 14 08:16

UPDATE 2-AstraZeneca buys Almirall lung drugs for up to $2.1 billion

* Almirall to get initial $875mln, up to $1.22bln in milestones * AstraZeneca gets access to Eklira and pipeline products * Almirall shares jump 8 percent (Adds analyst reaction, shares,) By Ben Hirschler LONDON, July 30 (Reuters) - AstraZeneca took a major step to build

30 Jul 14 08:10

AstraZeneca To Buy Respiratory Franchise Of Spain's Almirall

30 Jul 14 07:51

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.